Microarray analysis of ductal carcinoma in situ samples obtained by puncture from surgical resection specimens.
BMC Res Notes
; 14(1): 340, 2021 Aug 30.
Article
en En
| MEDLINE
| ID: mdl-34461994
ABSTRACT
OBJECTIVE:
The incidence of ductal carcinoma in situ (DCIS) is increasing due to more widespread mammographic screening. DCIS, the earliest form of breast cancer, is non-invasive at the time of detection. If DCIS tissues are left undetected or untreated, it can spread to the surrounding breast tissue. Thus, surgical resection is the standard treatment. Understanding the mechanism underlying the non-invasive property of DCIS could lead to more appropriate medical treatments, including nonsurgical options. DATA DESCRIPTION We conducted a microarray-based genome-wide transcriptome analysis using DCIS specimens obtained by puncture from surgical specimens immediately after surgery.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Carcinoma in Situ
/
Carcinoma Ductal de Mama
/
Carcinoma Intraductal no Infiltrante
Límite:
Female
/
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article